Increased phosphorylation of HER2 receptors provides several binding sites for different adaptor proteins involved in regulation of MAPK signaling pathway [17,18], and hence hyperactivates this signaling pathway in HER2-positive BC tumors. Here, ERBB2 is linked to breast cancer.